Celecoxib

ATP binding cassette subfamily B member 1 ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31623608 pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer. 2019 Oct 17 2
2 29541237 Celecoxib enhances sensitivity to chemotherapy drugs of T-cell lymphoma. 2018 Apr 1
3 29541415 Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death. 2018 Feb 16 8
4 28053596 Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. 2017 1
5 27798865 Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition. 2016 Oct 1
6 25691007 Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane. 2015 Jun 1
7 25736380 OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies. 2015 Aug 1
8 25916699 Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1-5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways. 2015 Jul 2
9 26407653 Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2. 2015 Dec 15 2
10 26417912 Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance. 2015 1
11 23803204 [Celecoxib enhances chemosensitivity of oral cancer cells by blocking cell cycle progression in vitro]. 2013 Jun 1
12 23991582 [Celecoxib enhances the chemotherapy sensitivity of KB/VCR cell lines to vincristine]. 2013 Aug 6
13 21835258 The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function. 2012 Jan 4
14 22305971 Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. 2012 May 15 1
15 22904679 Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo. 2012 Jul 1
16 20229271 Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib. 2011 Jan 3
17 20937780 Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. 2011 Jan 1
18 19685055 Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line. 2010 Apr 4
19 19426390 Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line. 2009 May 1
20 19447220 Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. 2009 Jul 1 2
21 19562670 Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-independent manner. 2009 Sep 1 2
22 18083230 Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. 2008 Jun 2
23 17510421 P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. 2007 May 15 7
24 17704658 Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein. 2007 Oct 3
25 11915030 The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. 2002 Apr 1